Triage of atypical glandular cell by SOX1 and POU4F3 methylation: A Taiwanese Gynecologic Oncology Group (TGOG) study

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chang, Cheng Chang ^a,b   Ou, Yu Che ^c   Wang, Kung Liahng ^d   Chang, Ting Chang ^e   Cheng, Ya Min ^f   Chen, Chi Hau ^g   Chu, Tang Yuan ^h   Hsu, Shih Tien ⁱ   Liou, Wen Shiung ^j   Chang, Yin Yi ^k   Wu, Hua Hsi ^l   Chen, Tze Ho ^m   Lai, Hung Cheng ^b,n,o  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^h BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

ⁱ TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^j KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^k CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^l TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^m CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

ⁿ TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^o TAIPEI MEDICAL UNIVERSITY   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTION FACTOR POU4F3; TRANSCRIPTION FACTOR SOX1; HOMEODOMAIN PROTEIN; POU4F3 PROTEIN, HUMAN; SOX1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR MARKER;

ADULT; AGED; AJAP1 GENE; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE; HIGH RISK PATIENT; HS3ST2 GENE; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PAX1 GENE; POLYMERASE CHAIN REACTION; POU4F3 GENE; PTPRR GENE; SENSITIVITY AND SPECIFICITY; SOX1 GENE; SQUAMOUS CELL CARCINOMA; TAIWANESE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; ZNF582 GENE; CLINICAL TRIAL; EPITHELIUM CELL; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; TAIWAN; UTERINE CERVIX TUMOR; VERY ELDERLY;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; DNA METHYLATION; EPITHELIAL CELLS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; SOXB1 TRANSCRIPTION FACTORS; TAIWAN; TRANSCRIPTION FACTOR BRN-3C; UTERINE CERVICAL NEOPLASMS;

EID: 84936817527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128705     Document Type: Article

References (35)

1. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993; 12(2):186-92. PMID: 8463044
2. Chen YY, You SL, Koong SL, Liu J, Chen CA, Chen CJ, et al. Screening frequency and atypical cells and the prediction of cervical cancer risk. Obstet Gynecol. 2014; 123(5):1003-11. doi: 10.1097/AOG.0000000000000206 PMID: 24785853
3. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr., Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004; 100(5):1035-44. PMID: 14983500
4. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer. 2005; 113(6):1005-9. PMID: 15515017
5. Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009; 114(3):383-9. doi: 10.1016/j.ygyno.2009.05.019 PMID: 19501894
6. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol. 2006; 107(3):701-8. PMID: 16507944
7. Lee KR, Darragh TM, Joste NE, Krane JF, Sherman ME, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol. 2002; 117(1):96-102. PMID: 11789738
8. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol. 2004; 121(1):87-92. PMID: 14750245
9. Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, de Oliveira Zambeli ER, do Amaral Westin MC, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol. 2004; 95(3):618-23. PMID: 15581973
10. Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. Clinical utility of atypical glandular cells (AGC) classification: cytohistologic comparison and relationship to HPV results. Gynecol Oncol. 2007; 104(2):366-71. PMID: 17049972
11. Chummun K, Fitzpatrick M, Lenehan P, Boylan P, Mooney E, Flannelly G. Diagnostic and therapeutic dilemma associated with atypical glandular cells on liquid-based cervical cytology. Cytopathology. 2012; 23(6):378-82. doi: 10.1111/j.1365-2303.2012.00981.x PMID: 22583085
12. Farkas SA, Milutin-Gasperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics. 2013; 8(11):1213-25. doi: 10.4161/epi.26346 PMID: 24030264
13. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol. 2009; 112(2):293-9. doi: 10.1016/j.ygyno.2008.10.012 PMID: 19054549
14. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008; 123(1):161-7. doi: 10.1002/ijc.23519 PMID: 18398837
15. Lai HC, Lin YW, Huang RL, Chung MT, Wang HC, Liao YP, et al. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer. 2010; 116(18):4266-74. doi: 10.1002/cncr.25252 PMID: 20564139
16. Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, et al. Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. PLoS One. 2012; 7(7):e41060. doi: 10.1371/journal.pone.0041060 PMID: 22815913
17. Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, et al. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev. 2006; 15(1):114-23. PMID: 16434596
18. Hesselink AT, Heideman DA, Steenbergen RD, Coupe VM, Overmeer RM, Rijkaart D, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res. 2011; 17(8):2459-65. doi: 10.1158/1078-0432.CCR- 10-2548 PMID: 21389098
19. Overmeer RM, Louwers JA, Meijer CJ, van Kemenade FJ, Hesselink AT, Daalmeijer NF, et al. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer. 2011; 129(9):2218-25. doi: 10.1002/ijc.25890 PMID: 21190187
20. Hansel A, Steinbach D, Greinke C, Schmitz M, Eiselt J, Scheungraber C, et al. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women. PLoS One. 2014; 9(3):e91905. doi: 10.1371/journal.pone.0091905 PMID: 24647315
21. Eijsink JJ, Lendvai A, Deregowski V, Klip HG, Verpooten G, Dehaspe L, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer. 2012; 130(8):1861-9. doi: 10.1002/ijc.26326 PMID: 21796628
22. Chen YC, Huang RL, Huang YK, Liao YP, Su PH, Wang HC, et al. Methylomics analysis identifies epigenetically silenced genes and implies an activation of beta-catenin signaling in cervical cancer. Int J Cancer. 2014; 135(1):117-27. doi: 10.1002/ijc.28658 PMID: 24310984
23. Chang CC, Huang RL, Wang HC, Liao YP, Yu MH, Lai HC. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma. Int J Gynecol Cancer. 2014; 24(2):201-9. doi: 10.1097/IGC.0000000000000054 PMID: 24407576
24. Chao TK, Ke FY, Liao YP, Wang HC, Yu CP, Lai HC. Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1). Diagn Cytopathol. 2013; 41(1):41-6. doi: 10.1002/dc.21758 PMID: 21710649
25. Lin YW, Tsao CM, Yu PN, Shih YL, Lin CH, Yan MD. SOX1 suppresses cell growth and invasion in cervical cancer. Gynecol Oncol. 2013; 131(1):174-81. doi: 10.1016/j.ygyno.2013.07.111 PMID: 23927962
26. Carter RL, Kang L, Darcy KM, Kauderer J, Liao SY, Rodgers WH, et al. A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study. Cancer Causes Control. 2012; 23(12):2013-21. doi: 10.1007/s10552-012-0081-0 PMID: 23073789
27. Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Darcy KM, Carter R, et al. Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study. Br J Cancer. 2011; 104(2):353-60. doi: 10.1038/sj.bjc.6606049 PMID: 21157448
28. Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Walker JL, Darcy KM, et al. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States. Int J Cancer. 2009; 125(10):2434-40. doi: 10.1002/ijc.24615 PMID: 19670419
29. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 2009; 35(3):210-20. doi: 10.1016/j.ctrv.2008.10.005 PMID: 19261387
30. Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks. Obstet Gynecol. 2010; 115(2 Pt 1):243-8. doi: 10.1097/AOG.0b013e3181c799a3 PMID: 20093895
31. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999; 91(3):252-8. PMID: 10037103
32. Stoler MH, Schiffman M, Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study G. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001; 285(11):1500-5. PMID: 11255427
33. Carreon JD, Sherman ME, Guillen D, Solomon D, Herrero R, Jeronimo J, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007; 26(4):441-6. PMID: 17885496
34. Ekonomou A, Kazanis I, Malas S, Wood H, Alifragis P, Denaxa M, et al. Neuronal migration and ventral subtype identity in the telencephalon depend on SOX1. PLoS Biol. 2005; 3(6):e186. PMID: 15882093
35. Fukuda H, Takahashi J, Watanabe K, Hayashi H, Morizane A, Koyanagi M, et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells. 2006; 24(3):763-71. PMID: 16223855